bioRxiv Science⌕ Search

Biology subjects

Carmona, A.

Publications and source records attributed to Carmona, A..

6 recordsLinked to original sources

Plasma plasmalogen levels and risk of lymph node positive breast cancer

Lymph node involvement is a key predictor of poor breast cancer prognosis. Systemic lipid alterations can contribute to cancer cell survival in lymph nodes, but their relevance in humans remains unclear. Here, we combine human epidemiologic analyses from the Nurses Health Study 2 and complementary mechanistic studies in mouse models to investigate how systemic lipid profiles relate to lymph node positive breast cancer. We show that in pre-diagnostic human plasma (n=511), lower levels of phosphatidylethanolamine (PE) and phosphatidylcholine (PC)-enriched plasmalogens are associated with increased risk of lymph node positivity, with stronger associations in samples collected closer to diagnosis. Consistent with the human data, lower levels of PE and PC-enriched plasma plasmalogens are found in mice with nodal involvement. Furthermore, in mice, dietary PUFA depletion reduces lipid oxidation in breast cancer cells in lymph nodes and promotes their survival and metastatic spread. These findings suggest that reduced levels of PE and PC-plasmalogens and decreased PUFA availability creates a lipid environment that enables breast cancer lymph node involvement.

cancer biology↗

Synchrotron XRF imaging reveals manganese accumulation in the Golgi and post-synapses of neurons and enhanced uptake in astrocytes

Manganese is an essential trace metal for humans, but excessive exposure can cause neurotoxicity, including parkinsonian syndromes, cognitive deficits, and has also been implicated in the pathogenesis of neurodegenerative diseases. Globally, tens of millions of people are exposed to elevated manganese levels through drinking water, exceeding the WHO recommended guideline. Despite its public health significance, the cellular and subcellular mechanisms underlying manganese neurotoxicity remain poorly defined, particularly its distribution across brain cell types and its specific intracellular targets. In this study, we investigated manganese accumulation in primary cultures of hippocampal neurons and astrocytes. Using a correlative imaging approach that combined cryo-fluorescence light microscopy with synchrotron X-ray fluorescence imaging, we mapped and quantified manganese at subcellular resolution. Our analysis revealed that manganese preferentially accumulates in the Golgi apparatus of both neurons and astrocytes. In neurons, manganese was also detected in dendrites at the postsynaptic density, suggesting a role in synaptic vulnerability. Quantitative elemental analysis showed that astrocytes accumulated 3 times more manganese than neurons. Furthermore, when neurons were co-cultured with astrocytes, their manganese uptake was significantly reduced, indicating a possible protective or buffering role of astrocytes. These findings identify key cellular and subcellular targets of manganese and highlight the Golgi apparatus as a major regulator of manganese neurotoxicity. This work provides a foundation for understanding cell type-specific responses to manganese exposure and may inform the development of targeted neuroprotection strategies. Significance statementManganese neurotoxicity impact millions of people worldwide. Understanding how manganese distributes within brain cells is critical for addressing its neurotoxic effects. This study identifies the Golgi apparatus and postsynaptic density as key sites of manganese accumulation and reveals astrocytes as major regulators of neuronal manganese uptake. These findings provide a cellular framework for developing targeted strategies to mitigate manganese-induced neurotoxicity.

neuroscience↗

Storage and transport of labile iron is mediated by lysosomes in axons and dendrites of hippocampal neurons

Iron dyshomeostasis in neurons, involving iron accumulation and abnormal redox balance, is implicated in neurodegeneration. In particular, labile iron, a highly reactive pool of intracellular iron, plays a prominent role in iron-induced neurological damage. However, the mechanisms governing the detoxification and transport of labile iron within neurons are not fully understood. This study investigates the storage and transport of labile ferrous iron Fe(II) in cultured primary rat hippocampal neurons. Iron distribution was studied using live cell confocal microscopy with a selective labile Fe(II) fluorescent dye, and synchrotron X-ray fluorescence microscopy (SXRF) for total iron distribution. Fluorescent labelling of the axon initial segment and of lysosomes allowed iron distribution to be correlated with these subcellular compartments. The results show that labile Fe(II) is stored in lysosomes within somas, axons and dendrites and that lysosomal labile Fe(II) is transported retrogradely and anterogradely along axons and dendrites. In addition, we have developed a methodological workflow to quantify labile Fe(II) relative to total iron in neurites. This method is based on correlative imaging of fluorescence microscopy of labile Fe(II) combined with quantitative elemental mapping of total iron by SXRF. Quantitative analysis revealed that after Fe(II) exposure, lysosomal Fe(II) accounts for a small but significant percentage of the total iron content in neurites. These result suggest that after exposure to labile Fe(II), iron is mainly present in a non-reactive form in neurons, while the smaller fraction of reactive labile Fe(II) is stored in lysosomes and can be transported along dendrites and axons.

neuroscience↗

Cytoplasmic aggregation of uranium in human dopaminergic cells after continuous exposure to soluble uranyl at non-cytotoxic concentrations

Uranium exposure can lead to neurobehavioral alterations in particular of the monoaminergic system, even at non-cytotoxic concentrations. However, the mechanisms of uranium neurotoxicity after non-cytotoxic exposure are still poorly understood. In particular, imaging uranium in neurons at low intracellular concentration is still very challenging. We investigated uranium intracellular localization by means of synchrotron X-ray fluorescence imaging with high spatial resolution (< 300 nm) and high analytical sensitivity (< 1 g.g-1 per 300 nm pixel). Neuron-like SH-SY5Y human cells differentiated into a dopaminergic phenotype were continuously exposed, for seven days, to a non-cytotoxic concentration (10 M) of soluble natural uranyl. Cytoplasmic submicron uranium aggregates were observed accounting on average for 62% of the intracellular uranium content. In some aggregates, uranium and iron were co-localized suggesting common metabolic pathways between uranium and iron storage. Uranium aggregates contained no calcium or phosphorous indicating that detoxification mechanisms in neuron-like cells are different from those described in bone or kidney cells. Uranium intracellular distribution was compared to fluorescently labeled organelles (lysosomes, early and late endosomes) and to fetuin-A, a high affinity uranium-binding protein. A strict correlation could not be evidenced between uranium and the labelled organelles, or with vesicles containing fetuin-A. Our results indicate a new mechanism of uranium cytoplasmic aggregation after non-cytotoxic uranyl exposure that could be involved in neuronal defense through uranium sequestration into less reactive species. The remaining soluble fraction of uranium would be responsible for protein binding and the resulting neurotoxic effects.

pharmacology and toxicology↗

Estimating daily intakes of manganese due to breast milk, infant formulas, or young child nutritional beverages in the United States and France: Comparison to sufficiency and toxicity thresholds

Background Although manganese (Mn) is an essential nutrient, recent research has revealed that excess Mn in early childhood may have adverse effects on neurodevelopment.Methods We estimated daily total Mn intake due to breast milk at average body weights by reviewing reported concentrations of breast milk Mn and measurements of body weight and breast milk intake at 3 weeks, 4.25 months, 7 months, and 18 months. We compared these figures to the Mn content measured in 44 infant, follow-up, and toddler formulas purchased in the United States and France. We calculated Mn content of formula products made with ultra-trace elemental analysis grade water (0 µg Mn/L) and with water containing 250 µg Mn/L, a concentration which is relatively high but less than the World Health Organization Health-based value of 400 µg Mn/L or the United States Environmental Protection Agency Health Advisory of 350 µg Mn/L.Results Estimated mean daily Mn intake from breast milk ranged from 1.2 µg Mn/kg/day (3 weeks) to 0.16 µg Mn/kg/day (18 months), with the highest intakes at the youngest age stage we considered, 3 weeks. Estimated daily Mn intake from formula products reconstituted with 0 µg Mn/L water ranged from 130 µg Mn/kg/day (3 weeks) to 4.8 µg Mn/kg/day (18 months) with the highest intakes at 3 weeks. Formula products provided 28 to 520 times greater than the mean daily intake of Mn from breast milk for the 4 age stages that we considered. Estimated daily Mn intake from formula products reconstituted with water containing 250 µg Mn/L ranged from 12 µg Mn/kg/day to 170 µg Mn/kg/day, which exceeds the United States Environmental Protection Agency Reference Dose of 140 µg Mn/kg/day for adults.Conclusions Mn deficiency is highly unlikely with exclusive breast milk or infant formula feeding, but established tolerable daily intake levels for Mn may be surpassed by some of these products when following labeled instructions.HighlightsMn deficiency is unlikely with exclusive breast milk or infant formula feeding.Breast milk Mn mean intake is 1.2 µg/kg/day (3 weeks)-0.16 µg/kg/day (18 months).Formula Mn intake range is 130 µg/kg/day (3 weeks)-4.8 µg/kg/day (18 months).Formula products reconstituted with 250 µg Mn/L water may exceed 140 µg Mn/kg/day.Formula products may surpass regulatory tolerable daily intake levels for Mn.Competing Interest StatementThe authors have declared no competing interest.1 List of abbreviationsAIAdequate IntakeANSESAgence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (French Agency for Food, Environmental and Occupational Health & Safety)DJAdose journalière admissible (daily admissible dose, tolerable daily intake)EFSAEuropean Food Safety AuthorityEUEuropean UnionFAOFood and Agriculture OrganizationHBVHealth-Based ValueINSPQInstitut national de santé publique du Québec (National Institute of Public Health of Québec)IOMInstitute of MedicineIQintelligence quotientJECFAJoint FAO/WHO Expert Committee on Food AdditivesLOAELLowest Observed Adverse Effect LevelMnManganeseMnSODmanganese superoxide dismutaseMRmagnetic resonanceNOAELNo Observed Adverse Effect LevelPIXEparticle induced X-ray emissionPNparental nutritionRBSRutherford backscatteringRfDReference DoseSCFScientific Committee on FoodT1RT1 relaxationTPNtotal parenteral nutritionU.S.United States Environmental Protection AgencyEPAEnvironmental Protection AgencyUSUnited StatesView Full Text

pharmacology and toxicology↗

Correlating STED and synchrotron XRF nano-imaging unveils the co-segregation of metals and cytoskeleton proteins in dendrites

Zinc and copper are involved in neuronal differentiation and synaptic plasticity but the molecular mechanisms behind these processes are still elusive due in part to the difficulty of imaging trace metals together with proteins at the synaptic level. We correlate stimulated emission depletion (STED) microscopy of proteins and synchrotron X-ray fluorescence (SXRF) imaging of trace metals, both performed with 40 nm spatial resolution, on primary rat hippocampal neurons. We achieve a detection limit for zinc of 14 zeptogram (10-21 g) per pixel. We reveal the co-localization at the nanoscale of zinc and tubulin in dendrites with a molecular ratio of about one zinc atom per tubulin-{beta} dimer. We observe the co-segregation of copper and F-actin within the nano-architecture of dendritic protrusions. In addition, zinc chelation causes a decrease in the expression of cytoskeleton proteins in dendrites and spines. Overall, these results indicate new functions for zinc and copper in the modulation of the cytoskeleton morphology in dendrites, a mechanism associated to neuronal plasticity and memory formation.

neuroscience↗